Substance P does not play a critical role in neurogenic inflammation in the rat masseter muscle

Jin Y Ro1, Youping Zhang, Michael Nies

  • 1Department of Biomedical Sciences, University of Maryland Baltimore School of Dentistry, 666 W. Baltimore Street, Baltimore, MD 21201, USA. jyr001@dental.umaryland.edu

Brain Research
|May 12, 2005
PubMed

Insights

Substance P (SP) does not significantly contribute to neurogenic inflammation in skeletal muscle. Experiments showed that blocking SP receptors did not inhibit mustard oil-induced swelling, indicating SP is not critical for this response in muscle tissue.

Area of Science:

  • Neuroscience
  • Inflammation Research
  • Skeletal Muscle Physiology

Background:

  • Neurogenic inflammation is a complex process involving the nervous system.
  • Substance P (SP) is a neuropeptide implicated in inflammatory responses in various tissues.
  • The role of SP in skeletal muscle neurogenic inflammation remains unclear.

Purpose of the Study:

  • To investigate the contribution of substance P (SP) to neurogenic inflammation in rat masseter muscle.
  • To determine if SP is essential for edema formation induced by inflammatory irritants in skeletal muscle.

Main Methods:

  • Rats were pretreated with neurokinin 1 (NK1) receptor antagonists (Sendide or L703,606) before mustard oil (MO) injection into the masseter muscle.
  • Edema was quantified by comparing the weight of injected versus non-injected muscles.
  • Exogenous SP and capsaicin were used to assess their direct effects on muscle swelling.

Main Results:

  • Pretreatment with NK1 receptor antagonists did not significantly inhibit MO-induced edema in the masseter muscle.
  • Exogenous SP induced swelling, but this was blocked by L703,606, suggesting endogenous SP release was insufficient.
  • Capsaicin, a known neurogenic inflammation agent, failed to induce edema in the masseter muscle, unlike in the hindpaw.

Conclusions:

  • Substance P (SP) does not play a critical role in inducing neurogenic inflammation in skeletal muscle tissue.
  • Unlike in cutaneous or joint tissues, SP-mediated pathways are not the primary drivers of inflammation in skeletal muscle.
  • These findings differentiate the inflammatory mechanisms in skeletal muscle from other tissue types.

Related Concept Videos